Skip to main content
    I

    iBio, Inc. Common Stock (IBIO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.75
    +0.04 (+5.86%)

    Market Cap: $49.79M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    iBio, Inc. Common Stock (IBIO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    iBio, Inc. Common Stock (IBIO) has a latest price of $0.75 on Nov 17, 2026, 80.4% below its 52-week high of $3.82. Its price fell 35.5% over the past 12 months. The month-end price fell 100.0% over the 10 years through Oct 2026, a compound annual decline of 55.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $2,600.00 in Oct 2016 and its lowest $0.68 in Jul 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IBIO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IBIO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 49.8%, and over 6 months it fell 50.1%. The month-end price fell 85.4% over the 3 years through Oct 2026, a compound annual decline of 47.3%.

    PeriodChange
    1 month-1.6%
    3 months-49.8%
    6 months-50.1%
    12 months-35.5%
    12 months, with dividends-35.5%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-85.4%-47.3%
    5 years-99.8%-71.2%
    10 years-100.0%-55.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 320.0%, and its weakest was 2022, when it fell 96.8%.

    YearCloseChange
    2026 through Oct 2026$0.77-60.2%
    2025$1.93-21.2%
    2024$2.45+78.8%
    2023$1.37-84.6%
    2022$8.89-96.8%
    2021$274.50-47.7%
    2020$525.00+320.0%
    2019$125.00-66.8%
    2018$376.70-58.1%
    2017$900.00-54.4%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 21.7% below its 50-day average of $0.96 and 53.4% below its 200-day average of $1.61.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.75
    52-week high$3.82-80.4%
    52-week low$0.68+10.8%
    50-day average$0.96-21.7%
    200-day average$1.61-53.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 91.1%.

    MeasureValue
    1-year beta2.25
    Largest fall, 1 year-77.0%
    Largest fall, 3 years-91.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IBIO

    What is IBIO's 1-year price change?

    iBio, Inc. Common Stock's price fell 35.5% over the past 12 months. With dividends included, the 12-month total return was -35.5%.

    What is IBIO's 5-year price change?

    iBio, Inc. Common Stock's month-end price fell 99.8% over the 5 years through Oct 2026, a compound annual decline of 71.2%. These figures leave out dividends.

    What is IBIO's 52-week high and low?

    iBio, Inc. Common Stock's 52-week high is $3.82 and its 52-week low is $0.68. Its latest price of $0.75 on Nov 17, 2026 is 80.4% below the high.

    What is IBIO's beta?

    iBio, Inc. Common Stock's 1-year beta against the S&P 500 is 2.25, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 77.0%.

    Is the IBIO chart free?

    Yes. Advanced Charting for IBIO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.